Skip Navigation

European Heart Journal 2004 25(8):626-628; doi:10.1016/j.ehj.2004.02.024
Copyright © 2004 by the European Society of Cardiology.
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Willems, R.
Right arrow Articles by Sipido, K. R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Willems, R.
Right arrow Articles by Sipido, K. R
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorial

Nonexcitatory stimulation as a novel treatment for heart failure: cause for excitement?

Rik Willemsa and Karin R Sipidob,*

a Division of Cardiology, University Hospital Gasthuisberg, Herestraat 49, B-3000 Leuven, Belgium
b Laboratory of Experimental Cardiology, University of Leuven, Leuven, Belgium

* Correspondence to: Tel.: +32-16-347-153; fax: +32-16-345-844
E-mail address: karin.sipido@med.kuleuven.ac.be

The first 10% of the full text of this article appears below.

This editorial refers to "Chronic electrical stimulation during the absolute refractory period of the myocardium improves severe heart failure"1 by G. Stix et al. on page 650.

The prevalence of heart failure is increasing and the "heart failure epidemic" is a growing socioeconomic burden to the public health sector.1 Although recent improvements in heart failure therapy have resulted in increased survival, the need for better treatment remains.2 In this issue, Stix et al.3 present their early experience with a new implantable device for the treatment of severe heart failure. The OptimizerTM II (Impulse Dynamics, NJ, USA) delivers electrical stimuli via 2 leads in the right ventricle. A 30-ms biphasic pulse is applied immediately after local activation, i.e., within the refractory period, a technique that has been coined "cardiac contractility modulation," . . . [Full Text of this Article]

Mechanisms that could explain CCM effects: favourable in the long-term?

Clinical relevance

Conclusion


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

Chronic electrical stimulation during the absolute refractory period of the myocardium improves severe heart failure
Guenter Stix, Martin Borggrefe, Christian Wolpert, Gerhard Hindricks, Hans Kottkamp, Dirk Böcker, Thomas Wichter, Yuval Mika, Shlomo Ben-Haim, Daniel Burkhoff, Michael Wolzt, and Herwig Schmidinger
EHJ 2004 25: 650-655. [Abstract] [FREE Full Text]